ROYAL BANK OF CANADA - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$1,000
-66.7%
4,750
+9.7%
0.00%
Q3 2022$3,000
+200.0%
4,329
+225.7%
0.00%
Q2 2022$1,000
-75.0%
1,329
-16.9%
0.00%
Q1 2022$4,000
-50.0%
1,600
-50.1%
0.00%
Q4 2021$8,000
-68.0%
3,207
-39.8%
0.00%
Q3 2021$25,000
-34.2%
5,323
-1.8%
0.00%
Q2 2021$38,000
+5.6%
5,421
+10.3%
0.00%
Q1 2021$36,000
-21.7%
4,913
-10.8%
0.00%
Q4 2020$46,000
-32.4%
5,509
-17.8%
0.00%
Q3 2020$68,000
+88.9%
6,702
+25.2%
0.00%
Q2 2020$36,000
+89.5%
5,354
+27.5%
0.00%
Q1 2020$19,000
+5.6%
4,198
+39.3%
0.00%
Q4 2019$18,000
-14.3%
3,0130.0%0.00%
Q3 2019$21,000
+10.5%
3,0130.0%0.00%
Q2 2019$19,000
-24.0%
3,0130.0%0.00%
Q1 2019$25,000
+56.2%
3,0130.0%0.00%
Q4 2018$16,000
-38.5%
3,013
+2.6%
0.00%
Q3 2018$26,000
+550.0%
2,938
+570.8%
0.00%
Q2 2018$4,000
+100.0%
4380.0%0.00%
Q1 2018$2,0000.0%4380.0%0.00%
Q4 2017$2,000
-50.0%
438
+15.9%
0.00%
Q3 2017$4,000
+33.3%
3780.0%0.00%
Q2 2017$3,000
-25.0%
3780.0%0.00%
Q1 2017$4,000
-98.2%
378
-98.2%
0.00%
Q2 2016$228,000
-12.0%
20,976
-0.9%
0.00%
Q1 2016$259,000
-4.1%
21,167
+0.9%
0.00%
Q4 2015$270,000
-0.4%
20,9760.0%0.00%
Q3 2015$271,000
-26.6%
20,9760.0%0.00%
Q2 2015$369,00020,9760.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 717,203$9,962,0000.89%
BANK HAPOALIM BM 147,504$2,049,0000.48%
MENORA MIVTACHIM HOLDINGS LTD. 246,000$3,417,0000.19%
Family Management Corp 16,500$229,0000.13%
Orbimed Advisors 564,900$7,846,0000.09%
SABBY MANAGEMENT, LLC 63,800$888,0000.03%
INGALLS & SNYDER LLC 41,550$577,0000.03%
Candriam S.C.A. 71,267$992,0000.02%
MONETARY MANAGEMENT GROUP INC 3,000$42,0000.02%
D.A. DAVIDSON & CO. 26,500$368,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders